Qizheng Li Xia Zhang Buqun Fan Yudie Yang Xiaonan Cui Jie Zhang Kaiteng Jiang Chunxia Zhang Bin Zhang
10.3389/fonc.2022.978005
Front Oncol
2022 Nov 30;12:978005.
tas-102 anlotinib case report mcrc metastatic colon cancer third-line
CC BY
https://pubmed.ncbi.nlm.nih.gov/36531025/
Case Reports
PMC9748473
36531025
Anlotinib combined with TAS-102 as the third-line treatment for a patient with metastatic colon cancer: A case report
2022